Core Viewpoint - Meili Tianyuan Healthcare (02373) announced the repurchase of 100,000 shares on November 27, 2025, for a total transaction amount of approximately HKD 2.37952 million, with an average price of about HKD 23.80 per share [1] Summary by Relevant Sections - Share Repurchase Activity - The company has repurchased a total of 615,000 shares from October 15, 2025, to the date of the announcement, with a total consideration of approximately HKD 18.68497 million [1]

Core Viewpoint - Meili Tianyuan Medical Health (02373) announced the repurchase of 100,000 shares at an average price of approximately HKD 23.80 per share, totaling around HKD 2.37952 million [1] Summary by Category Share Repurchase - The company repurchased a total of 615,000 shares from October 15, 2025, to the date of the announcement, with a total expenditure of approximately HKD 18.68497 million [1]

目前的股份成交价并不反映股份的内在价值和公司的实际业务前景。董事会相信，股份购回体现了管理 层对企业长期价值的坚定信心，有利于提升集团资本市场价值及股东回报能力。本次股份购回符合公司 及其股东的整体利益。 格隆汇11月27日丨美丽田园医疗健康(02373.HK)公告，公司于2025年11月27日于市场购回10万股公司股 份，总交易金额约2,379,520港元，交易平均价约每股23.80港元。自2025年10月15日至本公告日期止期 间，公司已购回共61.5万股股份，总对价约18,684,970港元。 ...

格隆汇11月27日丨美丽田园医疗健康(02373.HK)公告，11月27日耗资238万港元回购10万股。 ...

第 1 頁 共 6 頁 v 1.3.0 FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 美麗田園醫療健康產業有限公司 呈交日期： 2025年11月27日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02373 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Beauty Farm Medical and Health Industry Inc. 美麗田園醫療健康產業有限公司 * （於 開 曼 群 島 註 冊 成 立 的 有 限 公 司） （股 份 代 號：2373） 自願公告 市場股份回購 本公告由美麗田園醫療健康產業有限公司（「本公司」，連同其附屬公司統稱「本集 團」）自願刊發。 承董事會命 本公司欣然公佈，本公司於2025年11月27日於市場購回100,000股本公司股份，總 交易金額約2,379,520港元，交易平均價約每股23.80港元。自2025年10月15日至本 公告日期止期間，本公司已購回共615,000股股份，總對價約18,684,970港元。 本公司董事（「董事」）會（「董事會」）認為，目前的股份成交價並不反映股份的內在價 值和本公司的實際業務前景。董事會相信，股份購回體現了管理層對企業長期價值 的堅定信心，有利於提升本集團資本市場價值及 ...

Group 1 - The stock of Meili Tianyuan Medical Health (02373) fell over 11% during the trading session [1] - The cumulative decline for the month exceeds 30% [1] - As of the report, the stock price is down 7.28%, trading at HKD 22.42, with a transaction volume of HKD 57.48 million [1]

Investment Rating - The investment rating for the social services industry is "Positive" (maintained) [1] Core Insights - The report highlights a strong performance in the tourism sector, with Ctrip achieving a revenue of 18.37 billion yuan, a year-on-year increase of 15.5% [17] - The report indicates a structural shift in the toy industry, with a net closure of 9 stores in October 2025, leading to a total of 3,967 stores [29] - The restaurant industry is experiencing a contraction in tea supply while coffee continues to grow, with Haidilao focusing on increasing its takeout sales [36] Summary by Sections Ctrip Performance - Ctrip's Q3 2025 revenue reached 18.37 billion yuan, reflecting a year-on-year growth of 15.5% [17] - The adjusted EBITDA for Ctrip was 6.35 billion yuan, up 11.7% year-on-year [22] - The revenue breakdown shows ticketing, accommodation, vacation, and business travel management growing by 11.6%, 18.3%, 3.1%, and 15.2% respectively [21] Toy Industry - As of October 2025, the number of offline toy stores in China was 3,967, with a net decrease of 9 stores [29] - The average store efficiency for toy brands increased by 10% year-on-year, with top brands like Pop Mart showing significant growth [31] Restaurant Industry - The tea beverage sector is entering a contraction phase, while the coffee sector is accelerating [36] - As of October 2025, the average monthly store efficiency for the tea industry was 212,400 yuan, a 5.8% increase year-on-year [39] - The coffee industry saw a net increase of 5,600 stores, with an average monthly store efficiency of 289,000 yuan, up 1.2% year-on-year [39]

Core Viewpoint - The company is focusing on strategic upgrades through branding, chain expansion, and digitalization to enhance its market position and profitability, supported by both organic growth and acquisitions [1][2]. Group 1: Company Strategy - The company held a strategic upgrade conference, introducing three main strategies: "super brand, super chain, and super digitalization" [1]. - Branding efforts will include upgrading service processes, enhancing brand promotion, and collaborating with high-end real estate and well-known brands to increase brand visibility [1]. - The chain strategy aims to deepen presence in 20 key economically developed cities in China, increasing the number of cities with annual revenues exceeding 100 million yuan from 8 to 12, and boosting revenues in Beijing and Shanghai from over 600 million yuan to over 1 billion yuan [1]. - Digitalization initiatives involve a self-developed team creating 38 digital systems, with a self-research ratio of 70%, aimed at improving operational efficiency through precise marketing and restructured customer interaction processes [1]. Group 2: Recent Acquisitions - The company announced the acquisition of 19 Naieryer franchise stores in Zhuhai and Dongguan for 40 million yuan, which will add 19 new stores to its direct operation, including 2 medical beauty and 17 beauty stores [2]. - This acquisition is expected to generate approximately 75 million yuan in new revenue and 7.5 million yuan in net profit after tax for the group [2]. Group 3: Shareholder Returns and Financial Outlook - The company has launched a long-term shareholder return plan, committing up to 1.2 billion HKD over the next three years, including annual dividends of no less than 50% of net profit attributable to shareholders and share buybacks [2]. - Based on operational efficiency improvements, the profit forecast for 2025-2026 has been raised by 5% and 8% to 300 million and 360 million yuan, respectively, with current stock prices reflecting a P/E ratio of 20x and 17x for 2025-2026 [2].

智通财经APP获悉，中金发布研报称，基于美丽田园医疗健康(02373)经营提效，上调25-26年归母净利 润预测5%/8%至3.0/3.6亿元，当前股价对应25-26年20/17x P/E。维持跑赢行业评级及目标价42港元，对 应25-26年30/25x P/E，有49%上行空间。该行认为公司已通过"三强联合"巩固龙头地位，后续有望通过 品牌化、连锁化、数字化升级，进一步强化影响力、扩大市场份额、提升盈利能力，看好公司内生增长 与外延并购共同驱动下的成长空间。 中金主要观点如下： 进一步收购奈瑞儿19家加盟门店，拓展大湾区覆盖、增厚收入利润 公司公告以4,000万元人民币收购珠海和东莞的19家奈瑞儿加盟门店，收购完成后，奈瑞儿正式将珠海 和东莞纳入直营区域，将带动公司直营门店新增19家，含2家医美及17家生美门店，从而推动集团在大 湾区核心城市的辐射密度进一步加深，公司预计有望为集团新增近7,500万元收入、750万元税后净利 润。 积极提升股东回报，看好内生+外延驱动下的广阔空间 公司近期发布长期股东回报计划：未来三年将动用最高12亿港币提供股东回报，包括每年派息不低于归 母净利润50%及回购公司股份。该行 ...